Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Available NCT07629401

Provide Pre-approval Expanded Access of LY3437943

Sponsor: Eli Lilly and Company

Summary

Provide pre-approval single patient expanded access of retatrutide for patients.

Eligibility Criteria

Inclusion Criteria: \- Exclusion Criteria: \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07629401). StuddyBuddy aggregates publicly available trial information.